Skip to main content

Table 1 Demographic characteristics of the study and control groups

From: The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial

  Study Group N = 62 Control Group N = 59 p-value
Age, years (mean ± SD) 45.81 ± 10.83 43.83 ± 11.06 0.897
Post-menopause 18 (29.0%) 19 (32.2%) 0.839
Parity 1.91 ± 1.05 2.12 ± 1.23 0.327
IUD 8 (12.9%) 4 (6.7%) 0.268
Educational level (college or above) 22 (35.5%) 17 (28.8%) 0.652
Employed 42 (67.7%) 36 (61.0%) 0.559
History of TH 4 (6.5%) 7 (11.9%) 0.355
HR-HPV load (RLU/PC) (mean ± SD) 427.08 ± 771.50 416.06 ± 719.51 0.686
HR-HPV clearance 36 (58.1%) 32 (54.2%) 0.716
ASCUS/LSIL 13 (21.0%) 9 (15.3%) 0.522
  1. ASCUS/LSIL atypical squamous cell of undetermined significance/low-grade squamous intraepithelial lesion, HR-HPV high-risk human papilloma virus, IUD intra-uterine device, RLU/PC relative light unit/positive control, SD standard deviation, TH total hysterectomy